Bio-Rad Laboratories Inc. Watch

from 8-K 28 pages Bio-Rad Laboratories, Inc. $400,000,000 3.300% Senior Notes Due 2027 $800,000,000 3.700% Senior Notes Due 2032 Underwriting Agreement

from SC 13D/A 1 page /S/ Alice N. Schwartz Alice N. Schwartz, Individually Alice N. Schwartz Revocable Trust /S/ Alice N. Schwartz Alice N. Schwartz, Trustee

from SC 13G/A 1 page Exhibit 1 Joint Filing Agreement in Accordance With Rule 13d-1(f) Under the Securities Exchange Act of 1934, as Amended, the Undersigned Hereby Agree to the Joint Filing With All Other Reporting Entities (As Such Term Is Defined in the Schedule 13g) on Behalf of Each of Them of a Statement on Schedule 13g (Including Amendments Thereto) With Respect to the Class a Common Stock, Par Value $0.0001 Per Share, of Bio-Rad Laboratories, Inc., and That This Agreement Is Included as an Exhibit to Such Joint Filing. This Agreement May Be Executed in Any Number of Counterparts All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Hereby Execute This Agreement This 10th Day of December, 2014. Levin Capital Strategies, L.P. By:/S/ John A. Levin John A. Levin Chairman and Chief Executive Officer Lcs, LLC By:/S/ John A. Levin John A. Levin General Partner Lcs L/S, LLC By:/S/ John A. Levin John A. Levin General Partner Lcs Event Partners, LLC By:/S/ John A. Levin John A. Levin General Partner By:/S/ John A. Levin John A. Levin

from SC 13G 1 page Exhibit 1 Joint Filing Agreement in Accordance With Rule 13d-1(f) Under the Securities Exchange Act of 1934, as Amended, the Undersigned Hereby Agree to the Joint Filing With All Other Reporting Entities (As Such Term Is Defined in the Schedule 13g) on Behalf of Each of Them of a Statement on Schedule 13g (Including Amendments Thereto) With Respect to the Class a Common Stock, Par Value $0.0001 Per Share, of Bio-Rad Laboratories, Inc., and That This Agreement Is Included as an Exhibit to Such Joint Filing. This Agreement May Be Executed in Any Number of Counterparts All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Hereby Execute This Agreement This 8th Day of May, 2014. Levin Capital Strategies, L.P. By:/S/ John A. Levin John A. Levin Chairman and Chief Executive Officer Lcs, LLC By:/S/ John A. Levin John A. Levin General Partner Lcs Event Partners, LLC By:/S/ John A. Levin John A. Levin General Partner Lcs L/S, LLC By:/S/ John A. Levin John A. Levin General Partner By:/S/ John A. Levin John A. Levin

from 8-K 26 pages $425,000,000 Bio-Rad Laboratories, Inc. 4.875% Senior Notes Due 2020 Underwriting Agreement